Beyond Air (XAIR) Gross Margin (2023 - 2026)

Beyond Air (XAIR) posted Gross Margin of 4.93% for Q1 2026, down 63.95% sequentially from 13.67% in Q4 2025, and up 771.0% YoY from 0.57% in Q1 2025.

Beyond Air (XAIR) Gross Margin (2023 - 2026) Analysis & Trends

Beyond Air has reported Gross Margin for 4 years, with the latest figure at 4.93% in Q1 2026.

Quarterly Gross Margin rose 771.0% year-over-year to 4.93% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 3.28% (up 4817.0% YoY) and the FY2026 annual result came in at 3.28%, up 4817.0% from the prior year.
Gross Margin retreated to 4.93% in Q1 2026 per XAIR's latest filing, from 13.67% in the prior quarter.
Over five years, Gross Margin peaked at 13.67% in Q4 2025 and troughed at 413.56% in Q2 2023.
A 4-year average of 74.23% and a median of 34.33% in 2024 frame the typical range for Gross Margin.
The widest YoY moves for Gross Margin: up 36495 bps in 2024, down 5509 bps in 2024.
Over 4 years, Gross Margin stood at 91.05% in 2023, then soared by 78 bps to 20.06% in 2024, then soared by 168 bps to 13.67% in 2025, then sank by 64 bps to 4.93% in 2026.
According to Business Quant data, Gross Margin over the past three periods registered 4.93%, 13.67%, and 16.39% for Q1 2026, Q4 2025, and Q3 2025 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Gross Margin (Qtr)
1	Abbott Laboratories	198.70 Bn	193.10 Bn	7.27 Bn	57.71%
2	Stryker	125.85 Bn	122.37 Bn	4.50 Bn	68.27%
3	Medtronic	118.44 Bn	109.22 Bn	6.41 Bn	65.35%
4	Boston Scientific	72.64 Bn	72.10 Bn	3.85 Bn	70.71%
5	Edwards Lifesciences	51.94 Bn	47.69 Bn	1.35 Bn	77.46%
6	Dexcom	34.48 Bn	32.53 Bn	830.00 Mn	63.44%
7	GE HealthCare Technologies	33.60 Bn	31.49 Bn	2.18 Bn	41.17%
8	Koninklijke Philips	26.30 Bn	22.98 Bn	4.55 Bn	47.38%
9	Steris	23.00 Bn	22.52 Bn	684.20 Mn	45.84%
10	Beyond Air	3.72 Mn	-7.19 Mn	225,000.00	12.73%

Download Data